HL-60, a human promyelocytic leukemia cell line, can be differentiated to myeloid lineage by all- trans retinoic acid (ATRA), dimethylsulfoxide (DMSO) and n -butyric acid (n -BA), or to monocytoid(monocytic/macrophagic) lineage by phorbol-12-myristate-13-acetate (PMA) and ganglioside GM(3). The acti
Intranuclear distribution of the human myeloid cell nuclear differentiation antigen in HL-60 cells
β Scribed by David M. Duhl; Marek Gaczynski; Ryszard Olinski; Robert C. Briggs
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 688 KB
- Volume
- 141
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
β¦ Synopsis
Based on solubility properties, the human myeloid cell nuclear differentiation antigen exists as at least two distinct populations. Most is easily extracted from isolated nuclei in 0.35 M NaCI, while 20 percent resists such treatment. Compared to undigested nuclei, both the amount of myeloid cell nuclear differentiation antigen (MNDA) released from nuclei after DNase l treatment and the amount resisting further extraction in 0.35 M NaCl increased after DNA was digested with DNase I. Under these conditions, there was a concomitant decrease in the amount of M N D A that was extractable with 0.35 M NaCl. Mixing nuclear protein extracts that contain MNDA with nuclei from cells that do not express this protein demonstrated that the M N D A redistributes from the freely soluble form to the nuclear residual fraction as a consequence of DNase I digestion. These data are consistent with a model in which the amount of M N D A that is tightly bound to salt-washed nuclei is held constant in the presence of an excess of unassociated M N D A in the nucleus, and that the level of M N D A binding to this nuclear fraction increases in proportion to the extent of DNA damage resulting from DNase I digestion.
MATERIALS AND METHODS Growth and preparation of cells
Cells were maintained and grown in RPMI 1640 medium (Grand Island Biological Company, Grand Island, NY 1 containing 15% defined-supplemented calf serum (Hyclone Laboratories, Logan, UT). HL-60 cells were seeded at a cell density of 2 x lo5 cellsiml and KG-la cells at 1 x lo5 cellsiml. Cells were grown at 37Β°C in a humidified incubator containin 5% COz until they were harvested or subcultured. reached a density of 6-9 x 10 fi cellsiml, when they
π SIMILAR VOLUMES
## Abstract A human myeloid cell line, HLβ60, has been shown to terminally differentiate to mature granulocytes in the presence of dimethylsulfoxide (DMSO) and other compounds. A histone polypeptide (HP) with an apparent molecular weight of 12,500 has been identified among the acidβextractable chro
Human promyelocytic leukemia (HL-60) cells display a novel voltage-dependent outward current under voltage clamp. This current is present at low levels in the proliferative state and in granulocytes derived from HL-60 cells which were induced to differentiate with retinoic acid. It is elevated in ma
Human promyelocytic leukaemic cells, HLβ60, arrested in mitosis by nocodazole were released in the presence of 1Ξ±,25βdihydroxyvitamin D3 and thymidine or hydroxyurea. Cells moved from early G1 period to the G1/S boundary and differentiated. Furthermore, cells arrested at the G1/S boundary by double
The human myeloid cell nuclear differentiation antigen (MNDA) is expressed constitutively in cells of the myeloid lineage, appearing in myeloblast cells in some cases of acute myeloid leukemia and consistently being detected in promyelocyte stage cells as well as in all later stage cells including p
The role of magnesium ions in the differentiation of human promyelocytic leukemia HL-60 cells was investigated. When HL-60 extracellular magnesium was deficient (less than 0.01 mM), the total intracellular magnesium content and [3H] leucine incorporation rates decreased to 61 and 28%, respectively,